Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2021. Start Trial.
Date Value
December 31, 2025 -3.449M
June 30, 2025 -4.475M
December 31, 2024 -3.380M
June 30, 2024 -2.097M
December 31, 2023 -2.733M
Date Value
June 30, 2023 1.041M
December 31, 2022 -2.287M
June 30, 2022 -11.34M
December 31, 2021 -23.46M
June 30, 2021 -27.28M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Smith & Nephew plc 849.38M
Convatec Group Plc 140.70M
Tristel Plc 12.32M
Creo Medical Group Plc -59.13M
Abbott Laboratories 7.824B